Eurofins Scientific SE Share Price
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Euronext Paris
09:25:00 30/09/2026 pm IST
|
After hours 10:54:48 pm | |||
| 75.00 EUR | -1.57% |
|
74.87 | -0.17% |
| Market Cap | 1.32TCr 1.5TCr 1.25TCr 1.14TCr 2.13TCr 1,43800Cr 2.15TCr 15TCr 5.79TCr 73TCr 5.63TCr 5.51TCr 2,36400Cr | P/E 2026 * |
25.4x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.66TCr 1.88TCr 1.57TCr 1.42TCr 2.67TCr 1,80400Cr 2.7TCr 19TCr 7.26TCr 92TCr 7.06TCr 6.91TCr 2,96500Cr | EV / Sales 2026 * |
2.2x | EV / Sales 2027 * | 2.05x |
| Free-Float |
60.39% | Yield 2026 * |
1.05% | Yield 2027 * | 1.19% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ERF | Real-time | |
CBOE
| Real-time | ||
|
Börse Stuttgart
| ESF0 | Delayed | |
|
Xetra
| ESF0 | Delayed | |
|
CBOE
| 0MV5 | Real-time | |
|
Boerse Muenchen
| ESF0 | Real-time | |
|
Tradegate
| ESF0 | Real-time | |
|
OTC Markets
| ERFSF | Delayed | |
|
London S.E.
| 0MV5 | Delayed | |
|
Deutsche Boerse AG
| ESF0 | Delayed | |
|
Wiener Boerse
| ESF | End-of-day quote | |
|
Borsa Italiana
| 4ERF | End-of-day quote |
Last Transcript: Eurofins Scientific SE
| 1 day | -1.57% | ||
| 1 week | -1.52% | ||
| Current month | +3.39% | ||
| 1 month | +3.39% | ||
| 3 months | +9.39% | ||
| 6 months | +19.58% | ||
| Current year | +20.19% |
| 1 week | 74.96 |  | 78.92 |
| 1 month | 68.38 | | 79.22 |
| Current year | 56.84 | | 79.22 |
| 1 year | 54.86 | | 79.22 |
| 3 years | 39.47 | | 79.22 |
| 5 years | 39.47 | | 118.12 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 54 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/04/26 | Buy | 700 | 0.0004% | |||
| 19/04/26 | Sell | Chief Financial Officer | 3,000 | 0.0016% | ||
| 19/04/26 | Exercice | Executive/Senior Manager | 700 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.57% | -1.52% | +21.40% | +43.29% | 1.5TCr | |
| +4.16% | -0.30% | +58.96% | +94.17% | 7.15TCr | |
| -0.19% | +1.32% | +37.20% | +81.33% | 6.01TCr | |
| -1.16% | +2.78% | +9.52% | +37.31% | 4.89TCr | |
| +0.72% | +1.24% | +42.77% | +39.87% | 4.43TCr | |
| +1.23% | +9.36% | +346.66% | +697.06% | 4.38TCr | |
| +2.03% | +2.09% | +9.37% | +108.76% | 4.15TCr | |
| -0.67% | -0.45% | +4.47% | +46.37% | 3.01TCr | |
| +4.77% | +6.46% | +41.54% | +22.78% | 2.8TCr | |
| -0.08% | -2.37% | -19.78% | +355.38% | 2.53TCr | |
| Average | +0.92% | +0.08% | +55.21% | +152.63% | 4.08TCr | |
| Weighted average by Cap. | +1.19% | +0.48% | +62.46% | +151.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 753.54Cr 853.87Cr 712.97Cr 646.59Cr 1.21TCr 82TCr 1.22TCr 8.55TCr 3.3TCr 42TCr 3.21TCr 3.14TCr 1,34600Cr | 794.46Cr 900.24Cr 751.68Cr 681.69Cr 1.28TCr 86TCr 1.29TCr 9.02TCr 3.48TCr 44TCr 3.38TCr 3.31TCr 1,42000Cr |
| Net income | 53Cr 60Cr 50Cr 46Cr 85Cr 5.77TCr 86Cr 602.61Cr 232.25Cr 2.95TCr 225.9Cr 220.99Cr 9.49TCr | 66Cr 75Cr 62Cr 57Cr 106.13Cr 7.17TCr 107.17Cr 748.78Cr 288.58Cr 3.66TCr 280.7Cr 274.59Cr 12TCr |
| Net Debt | 336.6Cr 381.41Cr 318.47Cr 288.82Cr 541.49Cr 37TCr 546.83Cr 3.82TCr 1.47TCr 19TCr 1.43TCr 1.4TCr 60TCr | 303.37Cr 343.76Cr 287.04Cr 260.31Cr 488.04Cr 33TCr 492.85Cr 3.44TCr 1.33TCr 17TCr 1.29TCr 1.26TCr 54TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | €75.00 | -1.57% | 6,53,261 |
| 29/26/29 | €76.20 | -3.20% | 3,05,088 |
| 28/26/28 | €78.72 | +1.76% | 1,90,736 |
| 25/26/25 | €77.36 | -0.46% | 2,74,276 |
| 24/26/24 | €77.72 | +2.05% | 2,40,165 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
